CramerEffect
-
When Cramer Says Buy, I Check the Exit
When Jim Cramer says “buy,” the real question isn’t what he likes. It’s whether you’re late. This week he’s pounding the table on Marvell (MRVL) and Bausch Health (BHC). One is an AI infrastructure darling with hyperscaler tailwinds. The other is a battered pharma turnaround story that Wall Street still doesn’t fully trust. Two very…
-
Stop Treating Jim Cramer Like an Oracle (He’s a Thermometer)
Jim Cramer says buy, the stock pops. He trashes a name, it tanks. The real question isn’t what he said about Marvell (MRVL) and Bausch Health (BHC). It’s whether you should treat those calls as gospel—or as contrarian signals. Here’s the blunt answer: Cramer is better at spotting narratives than nailing entry points. And in…
-
Stop Trading Jim Cramer’s Personality and Start Trading the Setup
Jim Cramer says buy. The internet says fade him. So what’s the actual trade? When Cramer mentions a name like Marvell or Bausch Health, the knee-jerk reaction is tribal: either salute and hit “market buy,” or sprint to Reddit and short it out of spite. Both are lazy. The smarter move? Break down the setup,…
-
Don’t Trade Cramer’s Excitement — Trade the Chart
When Jim Cramer blesses a stock on Lightning Round, retail money doesn’t just trickle in — it stampedes. The real question isn’t whether he’s bullish. It’s whether you should fade the pop or ride the wave. Let’s talk Marvell (MRVL) and Bausch Health (BHC). Marvell (MRVL): Don’t Fight the AI Tape — But Don’t Chase…
You must be logged in to post a comment.